Exelon Patch

Active Ingredient(s): Rivastigmine
FDA Approved: * July 6, 2007
Pharm Company: * NOVARTIS PHARMS
Category: Alzheimers / Dementia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Exelon Patch Overview

Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects,[1] which typically include nausea and vomiting.[2] The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions.[2] Content...

Read more Exelon Patch Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rivastigmine

Recent Exelon Patch Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Rivastigmine or a similar ingredient: (2 results)

• EXELON Rivastigmine4 discussions
• RIVASTIGMINE

Related Exelon Patch Topics: